XML 22 R76.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 16 - Condensed Consolidating Financial Information Of Guarantor Subsidiary (Detail) - Condensed Consolidating Cash Flow Information (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended
Aug. 19, 2011
Feb. 29, 2012
Feb. 28, 2013
May 31, 2012
May 31, 2011
Net cash provided by (used in) operating activities $ 25,588 $ (4,662) $ (4,828)    
Net cash used in investing activities (2,265) (1,942,673) (6,915)    
Net cash provided by ( used in) financing activities 66 1,653,627 12,543    
Effect of exchange rate changes on cash and cash equivalents (3,029) (1,250) 142    
Increase (decrease) in cash and cash equivalents 20,360 (294,958) 942    
Cash and cash equivalents 322,963 28,005 19,520 18,578 302,603
Immucor Inc [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 250,386 314,304 8,093    
Immucor Inc [Member] | Ending Balance [Member]
         
Cash and cash equivalents 314,304 14,590 767    
Immucor Inc [Member]
         
Net cash provided by (used in) operating activities 64,243 (11,674) (16,071)    
Net cash used in investing activities (393) (1,941,668) (3,798)    
Net cash provided by ( used in) financing activities 68 1,653,628 12,543    
Increase (decrease) in cash and cash equivalents 63,918 (299,714) (7,326)    
Cash and cash equivalents     767 8,093  
Guarantor [Member] | Beginning Balance [Member]
         
Cash and cash equivalents (80) (89) (144)    
Guarantor [Member] | Ending Balance [Member]
         
Cash and cash equivalents (89) (144) (182)    
Guarantor [Member]
         
Net cash provided by (used in) operating activities 144 310 2,464    
Net cash used in investing activities (153) (365) (2,502)    
Increase (decrease) in cash and cash equivalents (9) (55) (38)    
Non-Guarantors [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 52,297 8,748 10,629    
Non-Guarantors [Member] | Ending Balance [Member]
         
Cash and cash equivalents 8,748 13,559 18,935    
Non-Guarantors [Member]
         
Net cash provided by (used in) operating activities (13,821) 16,680 8,691    
Net cash used in investing activities (1,719) (640) (615)    
Net cash provided by ( used in) financing activities (25,085) (10,753)      
Effect of exchange rate changes on cash and cash equivalents (2,924) (476) 231    
Increase (decrease) in cash and cash equivalents (43,549) 4,811 8,306    
Cash and cash equivalents     18,935 10,629  
Intersegment Elimination [Member]
         
Net cash provided by (used in) operating activities (24,978) (9,978) 88    
Net cash provided by ( used in) financing activities 25,083 10,752      
Effect of exchange rate changes on cash and cash equivalents (105) (774) (88)    
Cash and cash equivalents     (182) (144)  
Total [Member] | Beginning Balance [Member]
         
Cash and cash equivalents 302,603 322,963 18,578    
Total [Member] | Ending Balance [Member]
         
Cash and cash equivalents 322,963 28,005 19,520    
Total [Member]
         
Net cash provided by (used in) operating activities 25,588 (4,662) (4,828)    
Net cash used in investing activities (2,265) (1,942,673) (6,915)    
Net cash provided by ( used in) financing activities 66 1,653,627 12,543    
Effect of exchange rate changes on cash and cash equivalents (3,029) (1,250) 142    
Increase (decrease) in cash and cash equivalents 20,360 (294,958) 942    
Cash and cash equivalents     $ 19,520 $ 18,578